Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · Sahlgrenska University Hospital
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases and Sarcopenia. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- All adult patients experiencing an acute flare-up of their bowel disease (ulcerative colitis or Crohn's disease) admitted to a hospital in the Region Västra Götaland and Stockholm are invited to participate in the study.
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 180 participants are expected to take part.
- Start date: 2021-04-01.
- Main results expected around 2027-05-01 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Sweden.
Main thing being measured
- Number of participants with increase in muscle mass as assessed by DEXA scan. (1 year)
In the researchers’ words
Sarcopenia is a condition characterized by significant muscle loss resulting in impaired muscle function. This condition is likely associated with a biological deviation leading to reduced reserves to withstand stressors, resulting in a poorer prognosis.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases; Sarcopenia |
| Lead sponsor | Sahlgrenska University Hospital |
| Collaborators | Ersta Hospital, Sweden |
| Enrollment | 180 (estimated) |
| Start date | 2021-04-01 |
| Primary completion (est.) | 2027-05-01 |
| First posted | 2024-03-08 |
| Last updated | 2024-03-08 |
| Official title | Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease and the Significance of Removing the Colon |
| ClinicalTrials.gov ID | NCT06300541 |
Interventions
- Colectomy (Procedure)
Observational study.
Full eligibility criteria (from the record)
Inclusion Criteria: * All adult patients experiencing an acute flare-up of their bowel disease (ulcerative colitis or Crohn's disease) admitted to a hospital in the Region Västra Götaland and Stockholm are invited to participate in the study. Exclusion Criteria: * Not wishing to participate in the study Inability to understand the language or study procedures
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Sahlgrenska University Hospital | Gothenburg | Sweden | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.